The mechanism through which stromal RARβ achieves its tumor-promoting effect probably involves the production of CXCL12/SDF-1 in stroma cells and the consequent activation of the Src-ErbB2-Akt signaling pathway in the breast cancer cells (Figure 2C). This evidence concerns the gene CXCL12 and neoplasm.